TILT raises $10M to push ahead on cancer immunotherapies

Finnish company TILT Biotherapeutics, which is developing cancer immunotherapies, has completed the first close of its financing round. 

Related Keywords

China ,Helsinki ,Eteläuomen Läi ,Finland ,Finnish ,Chinese ,Timo Ahopelto ,Pembrolizumab Keytruda ,Avelumab Bavencio ,Miia Kaye ,University Of Helsinki ,Merck Kga ,Pfizer Alliance ,Merck Kgaa ,Tesi Finnish Industry Investment Ltd ,Lifeline Ventures ,Finnish Industry Investment Ltd ,